A detailed history of Castleview Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Castleview Partners, LLC holds 5,298 shares of ABT stock, worth $621,243. This represents 0.42% of its overall portfolio holdings.

Number of Shares
5,298
Previous 5,321 0.43%
Holding current value
$621,243
Previous $606,000 0.33%
% of portfolio
0.42%
Previous 0.41%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$100.07 - $118.13 $2,301 - $2,716
-23 Reduced 0.43%
5,298 $604,000
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $18,030 - $20,126
179 Added 3.48%
5,321 $552,000
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $111,491 - $123,137
1,018 Added 24.68%
5,142 $584,000
Q4 2023

Feb 05, 2024

BUY
$90.19 - $110.4 $12,085 - $14,793
134 Added 3.36%
4,124 $453,000
Q3 2023

Oct 26, 2023

BUY
$95.53 - $114.62 $15,093 - $18,109
158 Added 4.12%
3,990 $386,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $1,511 - $1,684
-15 Reduced 0.39%
3,832 $417,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $372,620 - $438,596
3,847 New
3,847 $389,000
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $265,606 - $307,522
2,745 Added 305.0%
3,645 $353,000
Q2 2022

Aug 17, 2022

SELL
$102.07 - $123.37 $56.5 Million - $68.3 Million
-553,866 Reduced 99.84%
900 $97,000
Q2 2022

Aug 16, 2022

BUY
$102.07 - $123.37 $55.9 Million - $67.6 Million
548,048 Added 8157.9%
554,766 $60.3 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $488 Million - $595 Million
-4,277,920 Reduced 99.84%
6,718 $795,000
Q4 2021

Feb 17, 2022

BUY
$115.53 - $141.46 $492 Million - $602 Million
4,254,854 Added 14285.7%
4,284,638 $603 Million
Q2 2021

Aug 17, 2021

BUY
$105.79 - $124.53 $811,515 - $955,269
7,671 Added 34.69%
29,784 $3.45 Million
Q1 2018

May 07, 2018

BUY
$56.27 - $63.62 $1.24 Million - $1.41 Million
22,113 New
22,113 $1.33 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.